A gain of function mutation in AKT1 increases hexokinase 2 and diminishes oxidative stress in meningioma
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology (BT/Med/30/SP11016/2015)
- Department of Science and Technology, Ministry of Science and Technology, India
- All-India Institute of Medical Sciences
- Anusandhan National Research Foundation (EMR/2017/001566)
This publication has 56 references indexed in Scilit:
- Interleukin-8: An evolving chemokineCytokine, 2022
- Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolismEBioMedicine, 2019
- AKT/PKB Signaling: Navigating the NetworkCell, 2017
- Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial PeptidoglycanCell, 2016
- Diverting Glycolysis to Combat Oxidative Stress2015
- Involvement of TNFα-induced TLR4–NF-κB and TLR4–HIF-1α feed-forward loops in the regulation of inflammatory responses in gliomaJournal of Molecular Medicine, 2011
- ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cellsFree Radical Biology and Medicine, 2009
- Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generationFree Radical Biology and Medicine, 2009
- Interleukin‐6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survivalInternational Journal of Cancer, 2008
- IL-1?-induced phosphorylation of PKB/Akt depends on the presence of IRAK-1European Journal of Immunology, 2002